U.S. Real Estate Stock News

Owens Corning recently reported quarterly results that came in below analysts’ expectations for revenue, adjusted operating income and EPS, reflecting softer market volumes. Even with this earnings miss, management pointed to higher margins and stronger operating cash flows driven by efficiency gains and a richer product mix. Next, we’ll explore how this earnings shortfall, alongside improved margins and cash generation, affects Owens Corning’s existing investment narrative. The best AI...

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...

Cogent Biosciences has completed its New Drug Application submission to the FDA for bezuclastinib in previously treated GIST, leveraging positive Phase 3 PEAK trial results and Breakthrough Therapy Designation under the Real-Time Oncology Review program. The PEAK data showed the bezuclastinib plus sunitinib regimen cut the risk of disease progression or death by half versus sunitinib alone, while maintaining a generally manageable safety profile and supporting expanded access programs for...

T. Rowe Price Group (NasdaqGS:TROW) has appointed Bill Cashel as Head of Alternatives for U.S. Wealth. The move marks a step in the firm's push into alternative investments and private market solutions. Cashel is expected to lead an expanded alternatives distribution team focused on U.S. wealth advisors. The appointment connects with offerings such as the OHA Flexible Credit Income Fund and work with Oak Hill Advisors and Goldman Sachs Asset Management. T. Rowe Price, long known for its...

UnitedHealth Group (NYSE:UNH) has settled a class-action lawsuit over denials of coverage for mental health and substance use disorder treatment. The settlement ends long running litigation related to behavioral health benefits and alleged violations of mental health parity requirements. This resolution comes as the company faces broader regulatory attention on how insurers handle behavioral health care. For investors looking at NYSE:UNH, this settlement relates directly to a core part of...

United Therapeutics recently reported that its Phase 3 TETON-1 trial of nebulized Tyvaso in idiopathic pulmonary fibrosis met the primary endpoint, showing a statistically significant improvement in lung function versus placebo over 52 weeks with no new safety issues. When combined with the earlier TETON-2 results, the data set provides two positive late-stage studies in IPF and supports United Therapeutics’ plan to seek a priority FDA review to expand Tyvaso’s labeled indications. We’ll now...

Generation Investment Management has already exited its position in Jones Lang LaSalle (JLL), citing rising competition and a belief that the company no longer stands out within commercial real estate services, while JLL’s own recent report underscores a global shortage of premium, post-2020 office space. This combination of an investor stepping back amid competitive pressures and JLL highlighting scarcity in top-tier real estate stock raises important questions about how the company’s...

Dividend policy and fresh guidance put Kanzhun in focus Kanzhun (NasdaqGS:BZ) has moved into the spotlight after its board approved an annual dividend policy, paired with new earnings guidance and detailed results for the fourth quarter and full year 2025. See our latest analysis for Kanzhun. Despite the dividend policy and earnings update drawing attention, Kanzhun’s recent share price performance has been weak, with a 30 day share price return of a 16.7% decline and a 90 day share price...

Wondering if Meritage Homes at around US$61.84 is a bargain or fairly priced? This article focuses on what the current share price might be telling you about value. The stock has returned 1.5% over the last 7 days, while the 30 day return sits at an 18.0% decline and the one year return is a 10.7% decline, despite 3 year and 5 year returns of 12.0% and 39.0% respectively. Recent attention on Meritage Homes has centered on its share price performance and how housing related names are being...

Commercial Metals Company recently reported past second-quarter and six-month results to February 28, 2026, showing higher sales of US$2,132.02 million and US$4,252.33 million respectively, alongside a move from a prior six-month loss to net income of US$270.31 million and meaningfully improved earnings per share from continuing operations. Alongside these results, the company completed a sizable share repurchase program totaling 15,131,239 shares for US$702.21 million and lifted its regular...

Marsh & McLennan Companies (NYSE:MRSH) has announced a leadership transition at its consulting and risk businesses. Ted Moynihan has been named President and CEO of Marsh Management Consulting and Oliver Wyman. Nick Studer has been appointed President and CEO of Marsh Risk. For investors tracking NYSE:MRSH, these moves come with the shares at $173.45 and a mixed return profile, including a 7.9% gain over 3 years and 49.6% over 5 years, alongside a 27.7% decline over the past year. The...

XPeng (XPEV) is back in focus after reporting March deliveries of 27,415 vehicles, an 80% month over month jump, alongside full year 2025 results that showed higher revenue and a narrower net loss. See our latest analysis for XPeng. Despite the strong delivery update and global expansion plans into Mexico, XPeng’s 7 day share price return of 9.28% decline and year to date share price return of 16.25% decline suggest investors are still cautious. At the same time, the 3 year total shareholder...

If you are wondering whether Westinghouse Air Brake Technologies at around US$249.91 is priced for perfection or still offers value, the next sections will help you size that up clearly. The stock's recent returns show a mixed picture, with a 1.7% gain over the past 7 days, a 5.3% decline over 30 days, and rises of 15.5% year to date, 36.7% over 1 year, 160.2% over 3 years, and 223.8% over 5 years. These moves are playing out against a backdrop of ongoing interest in rail technology, freight...

Avantor, Inc. has announced that its Chief Financial Officer and Executive Vice President, R. Brent Jones, will leave the company on or before June 24, 2026, with Senior Vice President and Chief Accounting Officer Steve Eck stepping in as interim CFO to maintain continuity in financial reporting and controls. This leadership transition concentrates financial oversight in the hands of a long-serving internal finance leader, which may influence how investors assess Avantor’s risk management,...

Salesforce (NYSE:CRM) has integrated Solutions by Text's FinText platform directly into Salesforce Marketing Cloud. The update enables compliance-first SMS, MMS, and RCS messaging to run natively inside Journey Builder. Regulated industries, including consumer finance, can now manage personalized, two-way mobile campaigns within their existing Salesforce workflows. For Salesforce, this development sits at the intersection of marketing automation and regulatory compliance, two areas that...

Microsoft plans to invest over US$1b in cloud and AI infrastructure in Thailand as part of a broader regional build out. The company is securing exclusive power supply arrangements for certain U.S. data centers to support AI related capacity. New partnerships focus on sovereign AI, compliance centric cloud services and skills training for governments and enterprises. Microsoft (NasdaqGS:MSFT) is committing more than US$1b to Thailand as it extends its cloud and AI footprint in Southeast...

If you are wondering whether Truist Financial's current share price reflects its underlying worth, the recent mix of returns provides plenty to think about. The stock last closed at US$45.97, with a 1.4% gain over 7 days, a 6.8% decline over 30 days, a 7.6% decline year to date, a 17.5% return over 1 year, a very large 69.3% return over 3 years, and a 1.6% decline over 5 years. Recent headlines around Truist Financial have focused on the broader banking sector, regulatory scrutiny, and...

On March 26, 2026, Ingevity Corporation entered into a Second Amended and Restated Credit Agreement that extended the maturity of its revolving credit facility by five years, reduced total commitments from US$1 billion to US$750 million, and repaid US$512.1 million of outstanding revolving loans. This move reshapes Ingevity’s financial toolkit, signaling an emphasis on disciplined liquidity management, lower standby borrowing capacity, and a refreshed banking agreement with updated covenant...

In March 2026, Hopscotch Air, an FAA-certificated air taxi operator, announced it is working with Archer Aviation to explore and test concepts for Archer’s future advanced air mobility operations, providing operational input on technologies and operating models. This collaboration brings real-world regional air taxi experience directly into Archer’s planning process, potentially sharpening how its aircraft, software and services are shaped around practical operator needs. Next, we’ll...

GigaCloud Technology has caught a lot of attention lately, and if you are wondering whether the current share price reflects its underlying value, this breakdown is designed to help you cut through the noise. The stock last closed at US$45.38, with returns of 8.0% over the past week, 2.3% over the past month, 17.1% year to date and 208.3% over the last year, which has put valuation firmly on the radar for many investors. Recent coverage has focused on GigaCloud Technology as a fast growing...

Conference spotlight and recent sentiment shift Zoetis (ZTS) is back in focus as Senior VP of Global Biologics R&D, Mahesh Kumar, presents at the World Vaccine Congress Washington 2026. The event is drawing attention to the company after a stretch of weaker investor sentiment. Recent setbacks around its osteoarthritis drug Librela, increased competition, negative social media coverage, and lowered annual guidance have weighed on the stock. This comes despite Zoetis previously exceeding...

KBR (KBR) has drawn attention after its first investment in AI firm Applied Computing, along with new contracts in Libya and a long-term maintenance deal with Saudi Aramco Total Refining and Petrochemical Company. See our latest analysis for KBR. The recent AI investment and Middle East and North Africa contract wins come after a 1-year total shareholder return decline of 25.08% and a 5-year total shareholder return that is roughly flat, while the year-to-date share price return decline of...

Alvotech has published its 2025 Annual Report and filed its Form 20-F, detailing progress in its biosimilar portfolio, including five approved products and a pipeline of nine additional candidates supported by global commercial partnerships. The company also reaffirmed its 2026 revenue guidance of US$650 million to US$700 million, highlighting a focus on cash flow and margin expansion through sales growth and operational efficiencies. With reaffirmed 2026 revenue guidance and expanded...